Montreux Equity Partners
   
 

Latest News

January 12, 2010
moksha8 and BioCryst Gain Approval for the Importation and Use of Peramivir in Mexico for the Treatment of H1N1 Influenza

November 18, 2009
Daniel K. Turner III Named to AlwaysOn Top Venture Capitalists in Inaugural VC 100 List

November 16, 2009
NeurogesX Receives FDA Approval of QutenzaTM (capsaicin) 8% Patch for Treatment of Postherpetic Neuralgia (PHN)

November 12, 2009
Montreux Equity Partners leads a $25 million financing in Moksha8, a specialty pharmaceutical company focused on Latin America



Action. Experience. Collaboration.

Montreux Equity Partners is a life sciences venture capital firm focused on building great pharmaceutical and medical device companies. Montreux's goal is to generate significant returns by investing in superior businesses with high quality management teams.

Montreux seeks investment opportunities in which it can add value beyond the commitment of capital. Montreux works with entrepreneurs and management teams who wish to operate in a dynamic partnership based on shared interests and common goals. Montreux's operating philosophy is anchored in a foundation of honesty, integrity, and uncompromising professionalism.

NVCA Member

©2010 Montreux Equity Partners. All Rights Reserved.